272 related articles for article (PubMed ID: 7920500)
1. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents].
Delmas PD; Lambert R; Capron MH
Rev Rhum Ed Fr; 1994 Feb; 61(2):126-31. PubMed ID: 7920500
[TBL] [Abstract][Full Text] [Related]
2. Misoprostol in the prevention of NSAID-induced gastric ulcer: a multicenter, double-blind, placebo-controlled trial.
Roth SH
J Rheumatol Suppl; 1990 Feb; 20():20-4. PubMed ID: 2109073
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
Lanza FL; Kochman RL; Geis GS; Rack EM; Deysach LG
Am J Gastroenterol; 1991 Dec; 86(12):1743-8. PubMed ID: 1962619
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic efficacy of misoprostol in peptic ulcer disease.
Watkinson G; Hopkins A; Akbar FA
Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
[TBL] [Abstract][Full Text] [Related]
5. Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoarthritis and rheumatoid arthritis.
Saggioro A; Alvisi V; Blasi A; Dobrilla G; Fioravanti A; Marcolongo R
Ital J Gastroenterol; 1991; 23(3):119-23. PubMed ID: 1742504
[TBL] [Abstract][Full Text] [Related]
6. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms.
Lanza FL; Fakouhi D; Rubin A; Davis RE; Rack MF; Nissen C; Geis S
Am J Gastroenterol; 1989 Jun; 84(6):633-6. PubMed ID: 2499187
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of non-steroidal antirheumatic drug-induced gastrointestinal lesions with misoprostol].
Bach GL; Stock KP; Hüdepohl M
Z Rheumatol; 1991; 50(3):175-80. PubMed ID: 1927064
[TBL] [Abstract][Full Text] [Related]
8. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
Dajani EZ; Agrawal NM
Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
[TBL] [Abstract][Full Text] [Related]
9. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
Lanza F; Peace K; Gustitus L; Rack MF; Dickson B
Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
[TBL] [Abstract][Full Text] [Related]
10. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.
Raskin JB; White RH; Jackson JE; Weaver AL; Tindall EA; Lies RB; Stanton DS
Ann Intern Med; 1995 Sep; 123(5):344-50. PubMed ID: 7625622
[TBL] [Abstract][Full Text] [Related]
11. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin.
Roth S; Agrawal N; Mahowald M; Montoya H; Robbins D; Miller S; Nutting E; Woods E; Crager M; Nissen C
Arch Intern Med; 1989 Apr; 149(4):775-9. PubMed ID: 2495779
[TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs.
Agrawal NM; Dajani EZ
J Assoc Acad Minor Phys; 1992; 3(4):142-8. PubMed ID: 1392409
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal antiinflammatory drugs for cancer pain: comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage.
Valentini M; Cannizzaro R; Poletti M; Bortolussi R; Fracasso A; Testa V; Sozzi M; Fornasarig M; Bortoluzzi F; Grazioli I
J Clin Oncol; 1995 Oct; 13(10):2637-42. PubMed ID: 7595718
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of misoprostol's clinical utility for gastric/duodenal ulcers seen under long-term use of non-steroidal anti-inflammatory drugs (NSAID)--I. Evaluation of mucosal prophylactic effects by a placebo-controlled double blind comparative study].
Shiokawa Y; Nobunaga M; Saito T; Sakita T; Miwa T; Nakamura K; Gunji A; Aoki K
Ryumachi; 1991 Oct; 31(5):554-71. PubMed ID: 1767349
[No Abstract] [Full Text] [Related]
15. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
Larkai EN; Smith JL; Lidsky MD; Graham DY
Am J Gastroenterol; 1987 Nov; 82(11):1153-8. PubMed ID: 3499815
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.
Geis GS; Stead H; Wallemark CB; Nicholson PA
J Rheumatol Suppl; 1991 Mar; 28():11-4. PubMed ID: 1903808
[TBL] [Abstract][Full Text] [Related]
17. [Ranitidine in the treatment of non-steroidal anti-inflammatory agent-induced damage of the stomach and duodenal mucosa. Results of a randomized, placebo-controlled double-blind study in patients with rheumatic diseases].
Simon B; Beckers KH; Biewer W; Bouzo MH; Dammann HG; Gebest HJ; Müller P; Schütz E
Z Gastroenterol; 1988 Jun; 26(6):310-3. PubMed ID: 3061183
[TBL] [Abstract][Full Text] [Related]
18. [Cost effectiveness of misoprostol therapy in prevention of NSAID-induced stomach ulcers].
Schwarz B
Wien Klin Wochenschr; 1995; 107(12):366-72. PubMed ID: 7631507
[TBL] [Abstract][Full Text] [Related]
19. [Sulglicotide in the prevention of gastric disease induced by NSAID. Double-blind controlled study versus placebo].
Magarò M; Altomonte L; Zoli A; Mirone L; Wielmarin A; Massari M; Destito G; Nazzari M; Psilogenis M
Minerva Dietol Gastroenterol; 1989; 35(1):27-30. PubMed ID: 2725926
[TBL] [Abstract][Full Text] [Related]
20. [Cost-effectiveness of preventive treatment with misoprostol in non-steroidal anti-inflammatory agents related gastric ulcers].
de Pouvourville G; Bader JP
Gastroenterol Clin Biol; 1991; 15(5):399-404. PubMed ID: 1906413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
